Skip to main content
. 2019 Jan-Feb;29(1):15–21. doi: 10.4103/ijn.IJN_437_17

Table 1.

Comparison of patients between non-AKI and AKI group with DVI

Parameters Overall patients (n=620) Non-AKI group (n=530) AKI group (n=90) p
Age group
 14-60 years (%) 580 (93.54) 495 (93.4) 85 (94.44) 0.007
 >60 years 40 (6.451) 35 (6.6) 5 (5.56)
Gender
 Male 353 (56.93) 275 (51.9) 75 (83.34) <0.001
 Female 267 (43.06) 255 (48.1) 15 (16.66)
Residence
 Urban 380 (61.29) 320 (60.37) 65 (72.22) <0.005
 Rural 240 (38.70) 210 (39.63) 25 (27.78)
Diagnosis
 DF (%) 454 (73.22) 430 (81.3) 24 (26.67) <0.001
 DHF (%) 141 (22.74) 95 (17.92%) 46 (51.1) <0.001
 DSS (%) 25 (4.03) 5 (0.94) 20 (22.23) <0.05
 DHF/DSS (%) 166 (26.77) 100 (18.86%) 66 (73.33) <0.001
Premorbid disease
 Diabetes (%) 37 (5.96) 20 (3.77) 17 (18.88) <0.001
 Hypertension (%) 35 (5.64) 20 (3.77) 15 (16.66) <0.001
 IHD (%) 25 (4.03) 18 (3.39) 7 (7.77) <0.001
 CHF (%) 5 (0.80) 3 (0.56) 2 (2.22) 0.88
 Hospitalization >3 days (%) 320 (51.61) 270 (50.94) 50 (55.55) 0.001
 Mean duration of hospitalization 3.94±0.62 2.24±0.76 5.94±0.82 <0.001
Urine examination
 Proteinuria (%) 90 (14.51) 65 (12.26) 25 (27.7) <0.001
 Hematurea (%) 15 (2.41) 7 (1.32) 8 (8.8) 0.002

AKI: Acute kidney injury, DF: Dengue fever, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome, IHD: Ischemic heart disease, CHF: Congestive heart failure, MODS: Multiorgan dysfunction syndrome (referred as dysfunction of ≥2 organ system); PT: Prothrombin time, aPTT: Activated prothrombin time